Efficacy of Multimodal Work‐Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary
Head & Neck · 2026
DOI: 10.1002/hed.70147 ↗Kurz gefasst
Fachartikel in der Zeitschrift Head & Neck, 2026. Verfasst von Robin W Jansen und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Otolaryngology-Head and Neck Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands. Hauptthemen laut MEDLINE: Neoplasms, Unknown Primary, Squamous Cell Carcinoma of Head and Neck, Lymphatic Metastasis, Head and Neck Neoplasms. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Background
Head and neck squamous cell carcinoma (HNSCC) often presents with cervical lymph node metastasis, with 1%–4% of cases presenting as cancer of unknown primary (CUP). CUP poses diagnostic and therapeutic challenges and is linked to poorer survival outcomes. Its incidence is expected to rise with the increasing prevalence of HPV‐positive HNSCC. This study evaluated the use of MRI, 18 F‐FDG PET, examination under anesthesia (EUA), and TORS‐assisted tonsillectomy and tongue base mucosectomy (TORS‐TE/TBM) in the work‐up of CUP.
Methods
This single‐center retrospective study included 79 patients with cytologically confirmed CUP (years 2019–2024). HPV‐positive ( n = 51) and HPV‐negative ( n = 28) cases were evaluated separately. Primary tumor detection rates for MRI, 18 F‐FDG PET and EUA were calculated. For HPV‐positive tumors TORS‐TE/TBM was additionally evaluated for primary tumor detection.
Results
In HPV‐positive cases MRI and 18 F‐FDG PET had detection rates of 45% individually (respectively) and 53% combined. Of detected cases, 37% were identified by a single modality. Post‐hoc image review increased the detection rate to 63%. Subsequent imaging‐guided EUA had a detection rate of 68%. When TORS‐TE/TBM was performed after negative EUA, tumor detection occurred in 50% of cases. Multimodal work‐up resulted in an over‐all detection rate of 75%. In contrast, HPV‐negative cases had a lower over‐all multimodal detection rate of 39%.
Conclusion
MRI and 18 F‐FDG PET each play a pivotal and complimentary role for the detection of primary tumors in HNSCC CUP. Image‐guided EUA and, in selected cases, TORS‐TE/TBM further improve detection. A multimodal approach including expert imaging interpretation is recommended for optimal tumor identification and treatment planning.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Otolaryngology-Head and Neck Surgery, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Department of Radiology and Nuclear Medicine, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Cancer Center Amsterdam, Imaging and Biomarkers, Amsterdam, the Netherlands.
- Amsterdam UMC, VU University Medical Center, Amsterdam, the Netherlands.
- Department of Pathology, Amsterdam UMC, Vrije Universiteit Amsterdam, Amsterdam, the Netherlands.
- Cancer Center Amsterdam, Cancer Biology and Immunology, Amsterdam, the Netherlands.
ORCID-Profile: Robin W Jansen
Zitieren
APA
Jansen, R. W., Martens, R. M., Abdulrahman, O., Peferoen, L., Leemans, C. R., Zwezerijnen, G. J. C., Hendrickx, J. J., & de Graaf, P. (2026). Efficacy of Multimodal Work‐Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary. Head & Neck. https://doi.org/10.1002/hed.70147
Vancouver
Jansen RW, Martens RM, Abdulrahman O, Peferoen L, Leemans CR, Zwezerijnen GJC, et al. Efficacy of Multimodal Work‐Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary. Head & Neck. 2026. doi:10.1002/hed.70147
BibTeX
@article{Jansen2026,
author = {Jansen, Robin W and Martens, Roland M and Abdulrahman, Obaida and Peferoen, Laura and Leemans, C René and Zwezerijnen, Gerben J C and Hendrickx, Jan-Jaap and de Graaf, Pim},
title = {Efficacy of Multimodal Work‐Up of Head and Neck Squamous Cell Carcinoma Lymph Node Metastasis of Unknown Primary},
journal = {Head & Neck},
year = {2026},
doi = {10.1002/hed.70147}
}
EUVIMED